Tous Actualités
Suivre
Abonner Sanacorp Pharmaholding AG

Sanacorp Pharmaholding AG

euro adhoc: Sanacorp Pharmaholding AG
Mergers - Acquisitions - Takeovers / Sanacorp buys von der Linde Group

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
22.12.2008
The pharmaceutical wholesale company Sanacorp Pharmahandel GmbH 
("Sanacorp GmbH"), which is an investment of Sanacorp Pharmaholding 
Aktiengesellschaft (ISIN: DE000763131) via its 50 percent interest in
the Italian holding company Millennium S.p.A., has signed an 
agreement on the acquisition of von der Linde Group, Düsseldorf in 
the afternoon of 22 December 2008. The performance of the agreement, 
along with other terms and conditions, is still subject to the 
competition authorities´ approval.
Sanacorp GmbH acquires from the family owners all shares in von der 
Linde GmbH & Co. Immobilienverwaltung KG, which in turn is sole 
shareholder of the operating company v.d. Linde Arzneimittel GmbH. 
This company distributes pharmaceutical products to pharmacies from 
its branches in Düsseldorf and Herne, generating sales revenue in the
past financial year 2007/2008 of approximately EUR 890 million with a
staff of 848. According to the sales and purchase agreement, Caesar 
und Loretz GmbH, which also belongs to Linde Group and produces basic
pharmaceutical substances, is intended to be removed from the 
corporate group. Sanacorp GmbH, which generates revenue of 
approximately EUR 2.7 billion from 15 branches and anticipates net 
income of some EUR 12 million for 2008, will use this transaction to 
strengthen its presence in North Rhine-Westphalia. This acquisition 
is expected to generate earnings net of refinancing expenses as early
as 2009; subsequently, the expected synergies are supposed to 
increase potential dividend payments by up to 25%.
Sanacorp Pharmaholding Aktiengesellschaft
The Management Board
end of announcement                               euro adhoc

Further inquiry note:

Florian Meilinger
Telefon: +49(089) 8581 239
E-Mail: f.meilinger@sanacorp.de

Branche: Wholesale
ISIN: DE0007163131
WKN: 716313
Index: CDAX, Classic All Share
Börsen: Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / regulated dealing
Börse Frankfurt / regulated dealing/general standard

Plus de actualités: Sanacorp Pharmaholding AG
Plus de actualités: Sanacorp Pharmaholding AG